Adverse Event Reporting

VAERS ID	1188632
Gender	Unknown
Age
StateCode	WI
Pharmaceutical Company	JANSSEN
Lot Number	1805022
Number of vaccinations
Vaccinated
Onset	2021-03-01
Condition

Symptoms

• Exposure via breast milk

Current Illness

Preexisting Conditions

Comments: Unknown

Other Medications

Previous Vaccinations

Allergies

Laboratory Data

Write-up

EXPOSURE VIA BREAST MILK; This spontaneous report received from a parent concerned a patient of unspecified age and sex.
The patient's weight, height, and medical history were not reported.
The patient's parent received covid-19 vaccine ad26.
cov2.
s (suspension for injection, transmammary, batch number: 1805022, expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 for an unspecified indication.
No concomitant medications were reported.
On MAR-2021, the subject experienced exposure via breast milk.
The action taken with covid-19 vaccine ad26.
cov2.
s was not applicable.
The outcome of exposure via breast milk was not reported.
This report was non-serious.
Version created to amend previously reported information on 10-Mar-2021.
Upon review the following information was amended: Event of Maternal exposure during breast feeding was changed to Exposure via breast milk.
; Sender's Comments: V0: Medical assessment comments not required as per standard procedure as the case is assessed non serious.